On Wednesday 13 November, the General Court of the European Union annulled certain provisions of a European Commission amending regulation (2021/468) which banned or placed under restriction certain hydroxyanthracene derivatives (HADs) used in food supplements (cases T-271/21 and T-274-21).
In 2021, the European Commission adopted this regulation, based on opinions from the European Food Safety Authority (EFSA), warning of potential health risks linked to high and prolonged consumption of...